Search results for "LBAS"

showing 10 items of 18 documents

Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C…

2016

Abstract Background: Complications from chronic hepatitis C virus (HCV) infection are a major cause of morbidity and mortality among individuals with inherited blood disorders (IBLD). Inability to tolerate ribavirin and frequent comorbidities have limited HCV treatment options in these patients. The aim of the C-EDGE IBLD study was to evaluate the efficacy and safety of a once-daily, fixed-dose combination of elbasvir 50 mg (EBR, an NS5A inhibitor) and grazoprevir 100 mg (GZR, an NS3/4A protease inhibitor) in patients with HCV infection and IBLD, including those with hemoglobinopathies. Methods: C-EDGE-IBLD was a randomized, double-blind, placebo-controlled study of treatment-naïve and trea…

0301 basic medicineElbasvirbusiness.industryRibavirinImmunologyCell BiologyHematologyHepatitis Cmedicine.diseaseBiochemistryVirologySickle cell anemiaVirus03 medical and health scienceschemistry.chemical_compound030104 developmental biologyBlood DisorderchemistryGrazoprevirmedicineElbasvir GrazoprevirbusinessBlood
researchProduct

Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.

2021

INTRODUCTION: We assessed the performance of direct-acting antivirals (DAAs) in hepatitis C virus (HCV)-infected people who use drugs (PWUDs) in terms of sustained virological response (SVR) and adherence rates in comparison to a location-matched cohort of non-PWUD HCV patients. METHODS: All consecutive HCV RNA-positive PWUDs were enrolled between 2015 and 2019. All subjects underwent DAA treatment according to international guidelines and then followed, at least, up to 12 weeks after the end of treatment (SVR12). The SVR and adherence to treatment was compared with that of non-PWUD HCV patients observed at hepatological units of the CLEO platform. Intention-to-treat analysis was performed.…

AdultMaleElbasvirmedicine.medical_specialtySofosbuvirSustained Virologic ResponseIntention to Treat AnalysiSubstance-Related DisordersHepatitis C virusmedicine.disease_causeAntiviral AgentsMedication Adherence03 medical and health sciences0302 clinical medicineRetrospective StudieInternal medicinemedicineHumansProspective StudiesRetrospective StudiesAntiviral AgentHepatologybusiness.industryGastroenterologyvirus diseasesGlecaprevirOdds ratioHepatitis C ChronicMiddle AgedSubstance-Related DisorderPibrentasvirdigestive system diseasesIntention to Treat AnalysisProspective StudieGrazoprevirItaly030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemalebusinessmedicine.drugHumanThe American journal of gastroenterology
researchProduct

Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the E…

2022

Background and aim: Direct Acting Antivirals(DAAs) achieve the highest rate of sustained viral re- sponse(SVR) in patients with genotype-1b(G1b) Hepatitis C virus(HCV) infection. Reducing treatment du- ration can simplify the management and improve adherence of therapy. Patients and methods: The study evaluates the efficacy of 8 weeks of elbasvir/grazoprevir regimen in 75 treatment-naïve(TN), G1b patients with mild-moderate fibrosis(Liver Stiffness by Fibroscan®< 9.0 kPa). Viral load(VL) has been evaluated by Roche TaqMan RT-PCR(LLOQ < 15 IU/ml). Results: Mean age was 61.0 ±14.2 years, 44% were male, mean LS by Fibroscan®was 6.1 ±1.8 kPa. Twenty-eight patients(37.3%) had an HOMA > …

CyclopropanesMalemedicine.medical_specialtyElbasvirGenotypeHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologyAntiviral AgentsSettore MED/07Insulin resistanceFibrosisInternal medicineQuinoxalinesRibavirinmedicineElbasvir GrazoprevirHumansAgedBenzofuransSulfonamidesHepatologybusiness.industryGastroenterologyImidazolesHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseAmidesHepatitis CSustained virological responseRegimenGlucoseGrazoprevirHCVRNADrug Therapy CombinationFemaleCarbamatesSafetyLiver stiffnessbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

PyCellBase, an efficient python package for easy retrieval of biological data from heterogeneous sources.

2019

Background Biological databases and repositories are incrementing in diversity and complexity over the years. This rapid expansion of current and new sources of biological knowledge raises serious problems of data accessibility and integration. To handle the growing necessity of unification, CellBase was created as an integrative solution. CellBase provides a centralized NoSQL database containing biological information from different and heterogeneous sources. Access to this information is done through a RESTful web service API, which provides an efficient interface to the data. Results In this work we present PyCellBase, a Python package that provides programmatic access to the rich RESTfu…

Databases FactualComputer scienceAnnotationBiological databaseRESTfulcomputer.software_genreNoSQLlcsh:Computer applications to medicine. Medical informaticsBiochemistryDatabase03 medical and health sciencesAnnotationUser-Computer Interface0302 clinical medicineInstallationStructural BiologyVariantMolecular Biologylcsh:QH301-705.5030304 developmental biologycomputer.programming_language0303 health sciencesBiological dataDatabaseApplied MathematicsRepositoryComputational BiologyPython (programming language)CellBaseComputer Science Applicationslcsh:Biology (General)Scripting language030220 oncology & carcinogenesislcsh:R858-859.7Web servicecomputerSoftwarePython
researchProduct

Fauna Europaea: Hymenoptera - Apocrita (excl. Ichneumonoidea)

2015

Fauna Europaea provides a public web-service with an index of scientific names (including important synonyms) of all living European land and freshwater animals, their geographical distribution at country level (up to the Urals, excluding the Caucasus region), and some additional information. The Fauna Europaea project covers about 230,000 taxonomic names, including 130,000 accepted species and 14,000 accepted subspecies. This represents a huge effort by more than 400 contributing specialists throughout Europe and is a unique (standard) reference suitable for many users in science, government, industry, nature conservation and education. Hymenoptera is one of the four largest orders of inse…

Fauna EuropaeaBiologisk systematikInsectaKulbastaviaMymarommatoideaBiodiversityStephanoideaHymenopteraBiological SystematicsCarbotripluridaBilateriaApocritataxonomic indexingBiology (General)lcsh:QH301-705.5ProctotrupoideaData ManagementChrysidoideaPterygotaEcologybiologyEcologyCenozoicCephalornisCircumscriptional namesEvanioideaEuropeBoltonocostidaeVespoideaIchneumonoideaTiphiinaeBiogeographyCircumscriptional nameCeraphronoideaNeogeneApoideaData PaperCoelenterataFauna EuropaeaChalcidoideaArthropodaBioinformaticsQH301-705.5HymenopteridaNephrozoaZoologyProtostomiaBasalPlatygastroideaZoologiCircumscriptional names of the taxon underBiodiversity informaticsTrigonalyoideaSystematicsAnimaliaEumetabolaEcology Evolution Behavior and Systematicsbiology.organism_classificationStrashila incredibilisHymenopteralcsh:Biology (General)NotchiaEcdysozoaCynipoideaApocritaZoologyBiodiversity Data Journal
researchProduct

Vicente Lleó Balbastre y el género sicalíptico

2016

Francisco 349 364UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASJosé:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]0211-5808 9678 Archivo de arte valenciano 446845 2016 97 5767312 Vicente Lleó Balbastre y el género sicalíptico Salvador MagranerBueno Camejo
researchProduct

Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry

2020

Germanbusiness.industrymedicinelanguageElbasvir GrazoprevirHepatitis Cmedicine.diseasebusinessVirologylanguage.human_languageZeitschrift für Gastroenterologie
researchProduct

Dinotrema cavernicola sp. n. (Hymenoptera, Braconidae, Alysiinae), a new species of the genus Dinotrema Foerster from caves of Spain

2014

Dinotrema cavernicola sp. n. was collected in two caves in Spain. This is the first Dinotrema species known to occur in caves. This new species is described and compared to D. affine (Fischer, 1973) and D. collybiae Munk & Peris-Felipo, 2014, species sharing a mid-longitudinal carina on the propodeum.

InsectaKulbastaviaDinotremaHymenopteraCarbotripluridaBraconidaetaxonomyGenusPropodeumlcsh:ZoologyBilaterialcsh:QL1-991AlysiinaePterygotageography.geographical_feature_categorybiologyCephalornisCircumscriptional namesCavernicolaBoltonocostidaeIchneumonoideaTiphiinaeCircumscriptional nameBraconidaeCoelenterataArthropodaHymenopteridaNephrozoaProtostomiaBasalZoologyDinotrema cavernicolaAnimaliaCircumscriptional names of the taxon undercavesCaveEumetabolaBraconidaeCephalornisEcology Evolution Behavior and SystematicsAlysiinaeCystomastacoides kiddoAlysiinaeAnimalianew speciesgeographyHymenopteraAnimaliaDipteraStrashila incredibilisbiology.organism_classificationHymenopteraNotchiaInsect ScienceAlysiiniEcdysozoaJournal of Hymenoptera Research
researchProduct

Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort.

2021

Background In patients treated for HCV infection, potential drug–drug interactions (DDIs) can occur among direct-acting antiviral drugs (DAAs) and comedications used. The real-life effectiveness and safety of elbasvir/grazoprevir (ELB/GZR) among co-medicated HCV patients was evaluated. Methods We prospectively evaluated consecutive patients from 15 clinical centres participating in PITER who were treated with ELB/GZR and had been followed for at least 12 weeks after treatment. Data were prospectively collected on the use of comedications (including discontinuation, dose modification and addition of drugs) and potential DDIs with DAAs. Results Of the 356 patients with at least 12-week post-t…

Male030312 virologycombination therapytreatment experienced patientsDrug Combinationchronic hepatitis C drug drug interactions virus genotype 1 treatment experienced patients pump inhibitor use combination therapy treatment naive liver fibrosisgrazoprevir elbasvir80 and overAge FactorPharmacology (medical)Drug InteractionsProspective StudiesChronicProspective cohort studyliver fibrosisAged 80 and over0303 health sciencesAge FactorsImidazolesMiddle AgedHepatitis CDrug CombinationsInfectious DiseasesTreatment OutcomeDrug InteractionGrazoprevirCohortdrug drug interactionsFemalepump inhibitor useHumanmedicine.drugmedicine.medical_specialtyElbasvirQuinoxalinetreatment naiveelbasvirAntiviral AgentsNO03 medical and health sciencesInternal medicineQuinoxalinesmedicinechronic hepatitis CElbasvir GrazoprevirHumansImidazoleAgedBenzofuransAntiviral AgentPharmacology...business.industrygrazoprevirCarbamazepineHepatitis C Chronicmedicine.diseaseComorbidityDiscontinuationBenzofuranAge Factors; Aged; Aged 80 and over; Antiviral Agents; Benzofurans; Drug Combinations; Drug Interactions; Female; Hepatitis C Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Quinoxalines; Treatment Outcomebusinessvirus genotype 1Antiviral therapy
researchProduct

Aspilota-group (Hymenoptera: Braconidae: Alysiinae) diversity in Mediterranean Natural Parks of Spain

2014

This work analyses the biodiversity of the Aspilota-group (Hymenoptera: Braconidae: Alysiinae) in three Mediterranean Natural parks: Natural Park of La Font Roja, Natural Park of Las Lagunas de la Mata-Torrevieja and Natural Park of La Tinença de Benifassà. Samples were carried out from April 2004 to December 2007. In total, 822 specimens, belonging to 52 species, were collected. Alpha, beta and gamma diversities were analysed, and the Tinença Park was proven to have higher diversity than the Font Roja and Torrevieja. Also, the structure of the Aspilota-group community was analysed.

Mediterranean climateInsectaKulbastaviaBiodiversityBiodiversity: Species Ecosystems & ConservationHymenopteraCarbotripluridaBraconidaeNatural parkBilaterialcsh:QH301-705.5AlysiinaePterygotabiologyEcologyEcologyCenozoicSouthern Europe and MediterraneanCephalornisBiodiversityCircumscriptional namesEuropeIchneumonoideaBoltonocostidaeTiphiinaeCircumscriptional namecommunityValenciaBraconidaeCoelenterataArthropodanatural parksHymenopteridaNephrozoaProtostomiaBasalCircumscriptional names of the taxon underNatural (archaeology)AnimaliaEumetabolaEcology Evolution Behavior and SystematicsAlysiinaeCystomastacoides kiddoAspilotabiology.organism_classificationStrashila incredibilisHymenopteralcsh:Biology (General)NotchiaEcdysozoaTaxonomic Paper
researchProduct